# S0777 (NCT00644228)

> Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT00644228
- Phase: PHASE3
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: National Cancer Institute (NCI)
- Conditions: DS Stage I Multiple Myeloma; DS Stage II Multiple Myeloma; DS Stage III Multiple Myeloma
- Interventions: Bortezomib; Dexamethasone; Laboratory Biomarker Analysis; Lenalidomide
- Enrollment: 525
- Primary outcome: Progression-free Survival

## Indexed commentary on S0777 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 20
- YouTube: 4
- Podcasts: 3
- X videos: 1

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=s0777-nct00644228

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT00644228", "email": "<work email>"}; the inbox owner confirms by the emailed link.